Keyphrases
Dose Escalation
100%
Granulocyte Colony-stimulating Factor (G-CSF)
100%
Doxorubicin
100%
Cyclophosphamide
100%
Hormone-sensitive Prostate Cancer
100%
Maximum Tolerated Dose
80%
Prostate-specific Antigen Level
60%
Median Survival Time
40%
Confidence Interval
20%
Anemia
20%
Neutropenia
20%
Nonhematologic
20%
Hematotoxicity
20%
Thrombocytopenia
20%
Median Survival
20%
Measurable Disease
20%
Objective Response
20%
Febrile Neutropenia
20%
Survival Duration
20%
Fixed-dose Combination
20%
Pelvic Irradiation
20%
Prostate-specific Antigen Response
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Granulocyte Colony Stimulating Factor
100%
Doxorubicin
100%
Cyclophosphamide
100%
Prostate Specific Antigen
80%
Maximum Tolerated Dose
80%
Median Survival Time
40%
Castration Resistant Prostate Cancer
40%
Anemia
20%
Neutropenia
20%
Thrombocytopenia
20%
Febrile Neutropenia
20%
Diseases
20%